LYEL Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $9.26

Capitalizzazione di Mercato (MRQ) $217M

P/E (TTM) -0.6

EPS (TTM) $-16.01

Ricavi (TTM) $27.0K

ROE (TTM) -93.3%

Intervallo 52 sett. $9–$40

LYEL Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 1

Data ex-dividendo	Split	Tipo
02 Giugno 2025	1-for-20	Inverso

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$36.0K

2019-12-31 → 2025-12-31

EPS$-16.06

2019-12-31 → 2025-12-31

Flusso di cassa libero$-151M

2021-12-31 → 2025-12-31

Margine netto-920285.2%

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	LYEL	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-0.6media 5 anni ≈-36.5	≈-36.5	·	·
P/S (TTM)	8024.3media 5 anni ≈31914.9	≈31914.9	14.6	Sopravvalutato
P/B (MRQ)	0.9media 5 anni ≈17.7	≈17.7	2.9	Sottovalutato
Prezzo / FCF (TTM)	-1.6media 5 anni ≈-74.4	≈-74.4	·	·
Prezzo / Flusso di cassa (TTM)	-1.6media 5 anni ≈-97.5	≈-97.5	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	0.9media 5 anni ≈17.7	≈17.7	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	LYEL	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-949981.5%media 5 anni ≈-305742.2%	≈-305742.2%	-752.1%	Debole
Margine EBITDA (TTM)	-914733.3%media 5 anni ≈-289750.0%	≈-289750.0%	-752.1%	Debole
Margine di Profitto Netto (TTM)	-920285.2%media 5 anni ≈-301538.5%	≈-301538.5%	-1884.8%	Debole
ROA (TTM)	-71.3%media 5 anni ≈-38.3%	≈-38.3%	-27.3%	Debole
ROE (TTM)	-93.3%media 5 anni ≈-51.7%	≈-51.7%	-31.2%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	LYEL	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		5.4media 5 anni ≈11.9	≈11.9	8.4	Bassa liquidità
Quick Ratio		5.0media 5 anni ≈11.6	≈11.6	5.3	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	LYEL	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-41.0%media 5 anni ≈107.7%	≈107.7%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-92.5%media 5 anni ≈-83.0%	≈-83.0%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-65.8%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	LYEL	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-16.06media 5 anni ≈$-12.71	≈$-12.71	·	·
Revenue / Share (Ricavi / Azione)	$0.00media 5 anni ≈$15.74	≈$15.74	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-8.78media 5 anni ≈$-187.92	≈$-187.92	·	·
Cash / Share (Liquidità / Azione)	$2.83media 5 anni ≈$1.09	≈$1.09	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	LYEL	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.0media 5 anni ≈0.0	≈0.0	0.3	Debole
Revenue / Employee (Ricavi / Dipendente)		≈$223.60	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media -20.5%

Prossimo report Nov 09, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-1.92	$-2.06	6.7%
31 Marzo 2026	Mag 11, 2026	$-1.10	$-2.41	54.4%
31 Dicembre 2025		$-7.50	$-2.28	-229.5%
30 Settembre 2025		$-2.13	$-2.70	21.0%
30 Giugno 2025		$-2.89	$-3.65	20.9%
31 Marzo 2025		$-3.54	$-3.67	3.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021	2020
Revenue	$36.0K	$61.0K	$130.0K	$85M	$11M	$8M
R&D Expense	·	·	$183M	$159M	$139M	$182M
SG&A Expense	$45M	$52M	$67M	$117M	$89M	$47M
Operating Expenses	$269M	$359M	$247M	$272M	$225M	$220M
Operating Income	$-269M	$-359M	$-247M	$-187M	$-215M	$-212M
Other Non-op	$-18M	$5M	$2M	$2M	$-161.0K	$2M
Income Tax	$0	·	·	·	·	·
Net Income	$-274M	$-343M	$-235M	$-183M	$-250M	$-204M
EPS (Basic)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
EPS (Diluted)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
Shares (Basic)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
Shares (Diluted)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
EBITDA	$-258M	$-339M	$-227M	$-169M	$-201M	·

Stato Patrimoniale 21

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$60M	$106M	$146M	$124M	$294M	$140M
Short-term Investments	$187M	$265M	$401M	$517M	$321M	$472M
Prepaid Expense	$14M	$9M	$8M	$11M	$11M	$5M
Current Assets	$261M	$380M	$555M	$651M	$626M	$618M
PP&E (Net)	$35M	$48M	$103M	$123M	$120M	$77M
PP&E (Gross)	$109M	$119M	$154M	$155M	$135M	$82M
Accum. Depreciation	$74M	$71M	$52M	$32M	$15M	$5M
Other Non-current Assets	$5M	$5M	$4M	$5M	$3M	$3M
Total Assets	$340M	$491M	$750M	$938M	$1.13B	$908M
Accounts Payable	$3M	$5M	$5M	$4M	$3M	$9M
Current Liabilities	$49M	$54M	$35M	$37M	$47M	$49M
Capital Leases	$42M	$51M	$57M	$63M	$67M	$51M
Other Non-current Liabilities	$517.0K	$3M	$4M	$4M	$5M	$532.0K
Total Liabilities	$92M	$108M	$95M	$104M	$198M	$190M
Common Stock	$2.0K	$1.0K	$25.0K	$25.0K	$24.0K	$2.0K
Paid-in Capital	$1.87B	$1.73B	$1.66B	$1.61B	$1.52B	$41M
Retained Earnings	$-1.62B	$-1.35B	$-1.00B	$-767M	$-584M	$-334M
AOCI	$242.0K	$291.0K	$-94.0K	$-8M	$-2M	$256.0K
Stockholders' Equity	$248M	$383M	$655M	$833M	$930M	$-293M
Liabilities + Equity	$340M	$491M	$750M	$938M	$1.13B	$908M
Shares Outstanding	21,251,000	14,744,000	12,698,000	12,479,000	242,738,000	15,570,000

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021	2020
D&A	$12M	$20M	$20M	$18M	$14M	$4M
Stock-based Comp	$42M	$33M	$47M	$82M	$62M	$33M
Restructuring	·	·	$6M	·	·	·
Other Non-cash	$71M	$128M	$4M	$-86M	$48M	·
Operating Cash Flow	$-150M	$-162M	$-164M	$-170M	$-126M	$-161M
CapEx	$780.0K	$464.0K	$3M	$24M	$66M	$51M
Investing Cash Flow	$54M	$122M	$184M	$-12M	$-122M	$-274M
Stock Issued	$50M	$0	$0	·	·	·
Stock Repurchased	·	·	·	$0	$0	$12M
Net Stock Activity	$50M	·	·	$0	$0	·
Financing Cash Flow	$50M	$1M	$2M	$11M	$401M	$477M
Net Change in Cash	$-46M	$-39M	$22M	$-170M	$153M	$42M
Free Cash Flow	$-151M	$-163M	$-166M	$-194M	$-192M	·

Redditività 5

Metrica	2025	2024	2023	2022	2021	2020
Operating Margin	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%	·
Net Margin	-762355.6%	-562285.2%	-180486.1%	-216.2%	-2349.5%	·
EBITDA Margin	-716291.7%	-555941.0%	-174429.2%	-199.6%	-1888.8%	·
ROA	-66.1%	-55.3%	-27.8%	-17.7%	-24.6%	·
ROE	-100.3%	-75.1%	-34.7%	-22.1%	-26.1%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Current Ratio		5.3	7.1	16.1	17.6	13.4	·
Quick Ratio		5.0	6.9	15.8	17.3	13.2	·

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.0	0.1	0.0	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$11.68	$1.30	$2.58	$3.34	$3.83	·
Revenue / Share	$0.00	$0.00	$0.00	$0.34	$78.36	·
Cash Flow / Share	$-8.78	$-0.62	$-0.65	$-0.69	$-928.86	·
Cash / Share	$2.83	$0.36	$0.57	$0.50	$1.21	·
EPS (TTM)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020
Revenue YoY	-41.0%	-53.1%	-99.9%	695.1%	37.3%	·
Revenue CAGR 3Y	-92.5%	-82.1%	-74.4%	·	·	·
Revenue CAGR 5Y	-65.8%	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020
Revenue TTM	$36.0K	$61.0K	$130.0K	$85M	$11M	·
Net Income TTM	$-274M	$-343M	$-235M	$-183M	$-250M	·
Market Cap	$654M	$3.77B	$9.85B	$17.32B	$37.58B	·
P/E	-1.9	-0.5	-2.1	-93.8	-84.1	·
P/S	18169.6	61875.6	75796.7	204.5	3528.2	·
P/B	2.6	9.9	15.0	20.8	40.4	·
P / Tangible Book	2.6	9.9	15.0	20.8	40.4	·
P / Cash Flow	-4.4	-23.2	-60.2	-102.1	-297.6	·
P / FCF	-4.3	-23.2	-59.2	-89.4	-196.0	·
Earnings Yield	-52.2%	-204.9%	-48.2%	-1.1%	-1.2%	·

Conto Economico 12

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$4.0K	$2.0K	$6.0K	$15.0K	$8.0K	$7.0K	$11.0K	$34.0K	$13.0K	$3.0K	$25.0K	$27.0K	$65.0K	$3.0K	$36M	$553.0K
R&D Expense	$40M	$37M	·	$28M	$35M	$43M	·	$40M	$40M	$43M	$44M	$47M	$45M	$42M	$44M	$36M
SG&A Expense	$10M	$10M	$11M	$11M	$10M	$14M	$15M	$12M	$12M	$13M	$16M	$19M	$19M	$26M	$30M	$34M
Operating Expenses	$47M	$44M	$128M	$37M	$47M	$57M	$201M	$51M	$52M	$56M	$59M	$66M	$63M	$66M	$73M	$69M
Operating Income	$-47M	$-44M	$-128M	$-37M	$-47M	$-57M	$-201M	$-51M	$-52M	$-56M	$-59M	$-66M	$-63M	$-66M	$-37M	$-69M
Other Non-op	$398.0K	$18M	$-16M	$-5M	$1M	$1M	$4M	$-43.0K	$-645.0K	$1M	$2M	$-326.0K	$1M	$-1M	$-14.0K	$35.0K
Net Income	$-45M	$-24M	$-141M	$-39M	$-43M	$-52M	$-192M	$-45M	$-46M	$-61M	$-51M	$-64M	$-67M	$-70M	$-36M	$-68M
EPS (Basic)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
EPS (Diluted)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
Shares (Basic)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
Shares (Diluted)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
EBITDA	$-47M	$-42M	·	$-37M	$-47M	$-54M	·	$-51M	·	$-51M	$-59M	$-66M	$-58M	$-66M	$-37M	$-64M

Stato Patrimoniale 21

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$73M	$91M	$60M	$124M	$99M	$120M	$106M	$100M	$133M	$126M	$286M	$224M	$109M	$116M	$206M	$223M
Short-term Investments	$131M	$163M	$187M	$196M	$178M	$181M	$265M	$340M	$358M	$401M	$289M	$371M	$503M	$532M	$450M	$391M
Prepaid Expense	$9M	$13M	$14M	$9M	$5M	$8M	$9M	$9M	$9M	$8M	$11M	$11M	$12M	$12M	$11M	$12M
Current Assets	$214M	$267M	$261M	$328M	$282M	$309M	$380M	$450M	$500M	$534M	$587M	$606M	$624M	$660M	$667M	$626M
PP&E (Net)	$31M	$33M	$35M	$37M	$39M	$44M	$48M	$88M	$93M	$98M	$108M	$114M	$119M	$126M	$128M	$126M
PP&E (Gross)	·	·	$109M	·	·	·	$119M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$74M	·	·	·	$71M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$6M	$5M	$5M	$3M	$3M	$3M	$5M	$5M	$4M	$4M	$4M	$5M	$5M	$3M	$4M	$4M
Total Assets	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Accounts Payable	$4M	$5M	$3M	$3M	$3M	$4M	$5M	$4M	$4M	$5M	$4M	$6M	$6M	$5M	$4M	$7M
Current Liabilities	$40M	$37M	$49M	$32M	$37M	$41M	$54M	$34M	$31M	$32M	$35M	$34M	$31M	$51M	$50M	$41M
Capital Leases	$37M	$39M	$42M	$44M	$47M	$49M	$51M	$51M	$53M	$55M	$59M	$60M	$62M	$65M	$66M	$67M
Other Non-current Liabilities	$537.0K	$527.0K	$517.0K	$3M	$3M	$3M	$3M	$4M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Total Liabilities	$77M	$77M	$92M	$79M	$87M	$93M	$108M	$89M	$88M	$91M	$97M	$98M	$97M	$157M	$154M	$191M
Common Stock	$2.0K	$2.0K	$2.0K	$2.0K	$1.0K	$30.0K	$1.0K	$26.0K	$26.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K
Paid-in Capital	$1.92B	$1.92B	$1.87B	$1.81B	$1.74B	$1.73B	$1.73B	$1.68B	$1.68B	$1.67B	$1.65B	$1.64B	$1.62B	$1.59B	$1.57B	$1.54B
Retained Earnings	$-1.69B	$-1.64B	$-1.62B	$-1.48B	$-1.44B	$-1.40B	$-1.35B	$-1.15B	$-1.11B	$-1.06B	$-949M	$-898M	$-834M	$-759M	$-689M	$-653M
AOCI	$-158.0K	$-9.0K	$242.0K	$201.0K	$57.0K	$158.0K	$291.0K	$760.0K	$-397.0K	$-404.0K	$-1M	$-2M	$-4M	$-10M	$-8M	$-7M
Stockholders' Equity	$234M	$274M	$248M	$329M	$299M	$337M	$383M	$531M	$567M	$603M	$698M	$737M	$784M	$820M	$868M	$881M
Liabilities + Equity	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Shares Outstanding	23,397,000	23,328,000	21,251,000	19,294,000	14,831,000	295,284,000	14,744,000	256,564,000	255,948,000	254,927,000	251,869,000	251,027,000	249,609,000	249,240,000	247,110,000	245,423,000

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
D&A	$2M	$2M	$2M	$3M	$3M	$3M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M
Stock-based Comp	$5M	$4M	$26M	$5M	$5M	$6M	$8M	$8M	$8M	$9M	$11M	$14M	$14M	$19M	$22M	$22M
Other Non-cash	·	$-21M	·	·	·	$-12M	·	·	·	$4M	·	·	$2M	·	·	$-6M
Operating Cash Flow	$-34M	$-39M	$-32M	$-29M	$-34M	$-55M	$-47M	$-35M	$-38M	$-42M	$-38M	$-39M	$-46M	$-37M	$-44M	$-48M
CapEx	$256.0K	$89.0K	$304.0K	$62.0K	$168.0K	$246.0K	$44.0K	$59.0K	$331.0K	$30.0K	$195.0K	$933.0K	$2M	$3M	$7M	$10M
Investing Cash Flow	$16M	$17M	$-31M	$3M	$13M	$69M	$54M	$2M	$45M	$22M	$100M	$153M	$32M	$-57M	$25M	$-26M
Stock Issued	·	·	$0	·	·	·	$0	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$522.0K	$52M	$222.0K	$50M	$183.0K	$1.0K	$437.0K	$0	$862.0K	$27.0K	$-143.0K	$1M	$-69.0K	$5M	$2M	$3M
Net Change in Cash	$-18M	$31M	$-63M	$25M	$-22M	$15M	$7M	$-33M	$8M	$-20M	$62M	$115M	$-14M	$-89M	$-17M	$-71M
Free Cash Flow	·	$-39M	·	·	·	$-55M	·	·	·	$-42M	·	·	$-48M	·	·	$-58M

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	-1183425.0%	-2213050.0%	·	-248353.3%	-589250.0%	-819528.6%	·	-148544.1%	·	-1852500.0%	-236156.0%	-244092.6%	-96240.0%	-2214566.7%	-104.2%	-12400.7%
Net Margin	-1118875.0%	-1207650.0%	·	-258973.3%	-533550.0%	-745642.9%	·	-131126.5%	·	-2022233.3%	-203412.0%	-236629.6%	-103013.9%	-2341800.0%	-101.6%	-12322.6%
EBITDA Margin	-1183425.0%	-2096450.0%	·	-248353.3%	-589250.0%	-770371.4%	·	-148544.1%	·	-1685033.3%	-236156.0%	-244092.6%	-88506.2%	-2214566.7%	-104.2%	-11643.6%
ROA	-12.8%	-6.2%	·	-7.6%	-8.2%	-9.3%	·	-6.3%	·	-7.7%	-5.7%	-6.9%	-6.9%	-6.5%	-3.2%	-12.7%
ROE	-16.8%	-7.9%	·	-9.0%	-9.9%	-11.1%	·	-7.3%	·	-8.8%	-6.7%	-8.0%	-8.0%	-7.8%	-3.8%	-15.5%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		5.4	7.2	·	10.3	7.6	7.5	·	13.4	·	16.5	16.7	17.6	20.3	12.9	13.3	15.2
Quick Ratio		5.1	6.9	·	10.0	7.5	7.3	·	13.1	·	16.3	16.4	17.3	19.9	12.7	13.0	15.0

Efficienza 1

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	·	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$9.99	$11.73	·	$17.06	$20.16	$1.14	·	$2.07	·	$2.37	$2.77	$2.94	$3.14	$3.29	$3.51	$3.59
Revenue / Share	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	·	$0.00	$0.00	$0.00	$0.00	$0.00	$0.15	$0.00
Cash Flow / Share	·	$-1.76	·	·	·	$-0.19	·	·	·	$-0.17	·	·	$-0.19	·	·	$-0.20
Cash / Share	$3.12	$3.89	·	$6.40	$6.66	$0.41	·	$0.39	·	$0.49	$1.14	$0.89	$0.44	$0.47	$0.83	$0.91
EPS (TTM)	$-16.01	$-16.98	·	$-27.48	$-28.83	$-29.53	·	$-25.28	$-22.00	$-18.67	$-0.76	$-0.84	$-0.73	$2.31	$2.39	$1.07

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$27.0K	$31.0K	·	$41.0K	$60.0K	$65.0K	·	$63.0K	$54.0K	$68.0K	$49M	$48M	$84M	$39M	$42M	$9M
Net Income TTM	$-248M	$-246M	·	$-326M	$-331M	$-335M	·	$-204M	$-210M	$-228M	$-190M	$-210M	$-182M	$-258M	$-237M	$-263M
Market Cap	$329M	$468M	·	$313M	$131M	$3.18B	·	$7.08B	·	$11.37B	$7.40B	$15.97B	$11.78B	$36.54B	$32.22B	$24.79B
P/E	-0.9	-1.2	·	-0.6	-0.3	-0.4	·	-1.1	-1.3	-2.4	-38.7	-75.7	-64.7	63.5	54.6	94.4
P/S	12175.1	15095.5	·	7642.3	2185.1	48880.9	·	112399.5	·	167202.1	152.7	329.3	139.9	934.0	769.6	2830.3
P/B	1.4	1.7	·	1.0	0.4	9.4	·	13.3	·	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Tangible Book	1.4	1.7	·	1.0	0.4	9.4	·	13.3	13.1	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Cash Flow	·	-12.2	·	·	·	-58.0	·	·	·	-270.6	·	·	-254.9	·	·	-518.0
Earnings Yield	-113.9%	-84.7%	·	-169.2%	-326.1%	-274.4%	·	-91.6%	-75.9%	-41.9%	-2.6%	-1.3%	-1.6%	1.6%	1.8%	1.1%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$36.0K	$61.0K	$130.0K	$85M	$11M
Margine Operativo %	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%
Utile netto	$-274M	$-343M	$-235M	$-183M	$-250M
EPS Diluito	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	5.3	7.1	16.1	17.6	13.4
Quick Ratio	5.0	6.9	15.8	17.3	13.2

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-151M	$-163M	$-166M	$-194M	$-192M

Proprietari istituzionali (13F) 95 filer · $240.0M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 95

Valore detenuto $240.0M

Nuove posizioni 26

Posizioni chiuse 9

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
26 (+6 vs trimestre precedente)	9 (+3 vs trimestre precedente)	29 (+4 vs trimestre precedente)	19 (+11 vs trimestre precedente)	+67K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
ARCH Venture Management, LLC	$45.525.211	3.247.162	18,97%	Azioni
MWG Caph Ltd	$31.029.810	1.008.116	12,93%	Azioni
VANGUARD GROUP INC	$25.437.516	826.430	10,60%	Azioni
GSK plc	$21.252.859	1.512.659	8,86%	Azioni
MWG Management Ltd.	$16.371.804	1.008.116	6,82%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$11.054.175	786.774	4,61%	Azioni
Orland Properties Ltd	$10.603.507	754.698	4,42%	Azioni
BlackRock, Inc.	$10.177.005	724.342	4,24%	Azioni
Almitas Capital LLC	$8.168.768	581.407	3,40%	Azioni
Foresite Capital Management V, LLC	$6.693.223	476.386	2,79%	Azioni
MILLENNIUM MANAGEMENT LLC	$5.162.996	367.473	2,15%	Azioni
Opaleye Management Inc.	$4.833.551	344.025	2,01%	Azioni
venBio Partners LLC	$4.744.643	337.697	1,98%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$4.365.887	310.636	1,82%	Azioni
Alphabet Inc.	$4.120.247	293.256	1,72%	Azioni
STATE STREET CORP	$2.603.774	185.322	1,08%	Azioni
HSG Holding Ltd	$2.139.801	152.299	0,89%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.829.169	130.190	0,76%	Azioni
NORTHERN TRUST CORP	$1.664.925	118.500	0,69%	Azioni
Qube Research & Technologies Ltd	$1.552.961	110.531	0,65%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.511.359	107.570	0,63%	Azioni
MARSHALL WACE, LLP	$1.493.516	106.300	0,62%	Azioni
Velan Capital Investment Management LP	$1.475.250	105.000	0,61%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.307.985	93.095	0,54%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.291.069	91.891	0,54%	Azioni
MIC Capital Management UK LLP	$1.222.743	87.028	0,51%	Azioni
GOLDMAN SACHS GROUP INC	$1.219.245	86.779	0,51%	Azioni
DIMENSIONAL FUND ADVISORS LP	$957.066	68.315	0,40%	Azioni
TWO SIGMA INVESTMENTS, LP	$743.624	52.927	0,31%	Azioni
JANE STREET GROUP, LLC	$646.455	46.011	0,27%	Azioni
Squarepoint Ops LLC	$594.624	42.322	0,25%	Azioni
Ikarian Capital, LLC	$577.188	41.081	0,24%	Azioni
MORGAN STANLEY	$520.553	37.050	0,22%	Azioni
CANADA PENSION PLAN INVESTMENT BOARD	$413.225	29.411	0,17%	Azioni
Point72 Asset Management, L.P.	$366.424	26.080	0,15%	Azioni
UBS Group AG	$365.048	25.982	0,15%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$363.895	25.900	0,15%	Opzione Call
Bank of New York Mellon Corp	$346.656	24.673	0,14%	Azioni
AMERICAN CENTURY COMPANIES INC	$344.787	24.540	0,14%	Azioni
Jump Financial, LLC	$308.482	21.956	0,13%	Azioni
Clearstead Advisors, LLC	$280.410	19.958	0,12%	Azioni
EntryPoint Capital, LLC	$272.710	19.410	0,11%	Azioni
CITADEL ADVISORS LLC	$262.665	18.695	0,11%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$252.900	18.000	0,11%	Azioni
CITADEL ADVISORS LLC	$251.495	17.900	0,10%	Opzione Put
Susquehanna Portfolio Strategies, LLC	$251.144	17.875	0,10%	Azioni
CITADEL ADVISORS LLC	$238.850	17.000	0,10%	Opzione Call
Allspring Global Investments Holdings, LLC	$226.837	16.145	0,09%	Azioni
RHUMBLINE ADVISERS	$217.234	15.462	0,09%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$199.510	14.200	0,08%	Opzione Put

Mostra tutti i 95 proprietari istituzionali →

Insider aziendali 25 insider · 14 dirigenti · 11 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Lynn Seely	President and CEO	21 Agosto 2026 S	63.899	6	$-353.079
Elizabeth Homans	Chief Executive Officer	16 Marzo 2022 A	·	0	$0
Charles W. Newton	Chief Financial Officer	21 Agosto 2025 S	15.306	0	$0
Stephen J. Hill	Chief Operating Officer	21 Agosto 2026 S	16.816	6	$-51.290
Jarrad Mattieu Aguirre	Chief Medical Officer	10 Settembre 2026 A	·	0	$0
David Shook	Chief Medical Officer	10 Settembre 2026 S	20.423	2	$-31.339
Gary K. Lee	Chief Scientific Officer	21 Agosto 2026 S	16.220	6	$-71.695
Veronica Sanchez Bulis	VP, Corporate Controller	10 Agosto 2026 S	14.799	6	$-96.909
Smital Shah	Chief Fin. and Bus. Officer	09 Marzo 2026 A	·	0	$0
Mark A Meltz	General Counsel	10 Febbraio 2026 A	·	0	$0
Matthew Lang	Chief Business Officer	10 Febbraio 2025 A	162.500	0	$0
Tina M. Albertson	Chief Medical Officer	24 Febbraio 2023 A	·	0	$0
Rahsaan Thompson	Chief Legal Officer	24 Febbraio 2023 A	·	0	$0
Heather D Turner	Chief General Counsel	16 Marzo 2022 A	·	0	$0
Mark Bachleda	Direttore	10 Giugno 2026 A	·	0	$0
Elizabeth G Nabel	Direttore	10 Giugno 2026 A	·	0	$0
Richard Klausner	Direttore	10 Giugno 2026 A	843.365	0	$0
Sumant Ramachandra	Direttore	10 Giugno 2026 A	200.000	0	$0
Cathy Friedman	Direttore	10 Giugno 2026 A	236.370	0	$0
Otis W Brawley	Direttore	10 Giugno 2026 A	35.640	0	$0
William Jl Rieflin	Direttore	10 Giugno 2026 A	·	0	$0
Hans Edgar Bishop	Direttore	14 Giugno 2024 A	4.685.614	0	$0
Robert Nelsen	Direttore	14 Giugno 2024 A	18.206.358	0	$0
Innovative Cellular Therapeutics Holdings Ltd	Proprietario del 10%	27 Luglio 2026 J	2.818.980	2	$-274
GSK plc	·	21 Giugno 2021 C	30.253.189	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 16 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IWC · iShares Trust	0,03%	32.319 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	1.674 SH	02 Ottobre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	8.183 SH	19 Agosto 2026	Giornaliero
IBB · iShares Trust	0,01%	57.662 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,00%	4.474 NS	31 Luglio 2026	N-PORT
IWM · iShares Trust	0,00%	222.823 SH	11 Settembre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,00%	8.835 SH	02 Ottobre 2026	Giornaliero
DCOR · Dimensional ETF Trust	0,00%	1.961 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	1.736 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	163.755 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	604.461 SH	19 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	54.398 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.151 SH	19 Agosto 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	409 NS	31 Luglio 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,00%	28.159 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	89.130 SH	11 Settembre 2026	Giornaliero

LYEL Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 14 analisti COMPRA

Target mediano $41.50 +348,2%

4 28,6% Acquisto forte

8 57,1% Compra

1 7,1% Mantieni

1 7,1% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

8 analisti · 2026-10-02

Target medio $37.88 +309,0%

← Sotto tutti i target Prezzo attuale $9.26

Basso$12.00 Media$37.88 Alto$49.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
LYEL	$654M	-1.9	-41.0%	-762355.6%	-100.3%	·
CAMP	$318M	-2.3	436.5%	-2298.5%	-183.4%	·
EVMN	$540M	-1.5	85.7%	-529.8%	-401.2%	·
AKBA	$427M	-80.5	47.5%	-2.3%	-17.3%	·
IVVD	$697M	-8.2	110.5%	-98.2%	-36.9%	·
MGNX	$102M	-1.4	-0.31%	-49.9%	-87.0%	·
KROS	$398M	8.9	·	35.7%	17.2%	·
RNAC	$188M	-1.4	-92.8%	-4658.6%	202.4%	·
SION	$1.84B	-21.9	·	·	-23.4%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

LYEL Lyell Immunopharma, Inc. - Common Stock